Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2025-12-24 @ 4:41 PM
Study NCT ID:
NCT07274566
Status:
COMPLETED
Last Update Posted:
2025-12-10
First Post:
2025-11-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Effects of an 8-Week Exer-Genie-Assisted Speed and ABC Drill Training Program on Speed, Hamstring Strength, and Vertical Jump Performance in Female Football Players
Sponsor:
Istanbul Rumeli University
Organization:
Study Overview
Official Title:
The Effects of an 8-Week Exer-Genie-Assisted Speed and ABC Drill Training Program on Speed, Hamstring Strength, and Vertical Jump Performance in Female Football Players
Status:
COMPLETED
Status Verified Date:
2025-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to examine the effects of an eight-week Exer-Genie®-assisted speed and agility-balance-coordination (ABC drill) training program on sprint performance, hamstring muscle strength, and vertical jump ability in young female football players. A total of 37 licensed female football players competing in the Turkish Women's Second League participated in the study. Participants were randomly assigned to an experimental group (n = 20) or a control group (n = 17). The study evaluates whether this integrated training approach enhances acceleration, force production, and neuromuscular control compared to regular team training alone.
Detailed Description:
Study Design and Participants The study involves 37 female football players from the Pendik Güven Women's Football Team (mean age 14.4 ± 1.4 years), licensed by the Turkish Football Federation. Participants were randomly assigned to an experimental group (n = 20) or a control group (n = 17).
Intervention Protocol The experimental group completed an Exer-Genie®-assisted sprint and ABC drill training program twice per week for eight weeks (total of 16 sessions). Each session was performed after a standardized warm-up and consisted of six 30-m sprint runs and technical drills. The sprints were performed with resistance applied using the 60-m Exer-Genie® device, with resistance intensity set at 10% of each athlete's body weight. The control group continued with their regular team training only.Outcome Measures 1. Sprint Performance: Assessed via 0-10 m, 10-30 m, and 30 m sprint times using the SmartSpeed electronic timing gate system. 2. Hamstring Strength: Assessed using the NordBord Hamstring Testing System. Specifically, the ISO Prone (0°) protocol was used to measure isometric hamstring strength and impulse values. 3. Vertical Jump: Assessed via the Countermovement Jump (CMJ) test using the ForceDecks system to evaluate lower-limb explosive performance.Statistical Analysis Data were analyzed using repeated-measures ANOVA to evaluate time, group, and interaction effects, with a significance level set at p \< 0.05.
Intervention Protocol The experimental group completed an Exer-Genie®-assisted sprint and ABC drill training program twice per week for eight weeks (total of 16 sessions). Each session was performed after a standardized warm-up and consisted of six 30-m sprint runs and technical drills. The sprints were performed with resistance applied using the 60-m Exer-Genie® device, with resistance intensity set at 10% of each athlete's body weight. The control group continued with their regular team training only.Outcome Measures 1. Sprint Performance: Assessed via 0-10 m, 10-30 m, and 30 m sprint times using the SmartSpeed electronic timing gate system. 2. Hamstring Strength: Assessed using the NordBord Hamstring Testing System. Specifically, the ISO Prone (0°) protocol was used to measure isometric hamstring strength and impulse values. 3. Vertical Jump: Assessed via the Countermovement Jump (CMJ) test using the ForceDecks system to evaluate lower-limb explosive performance.Statistical Analysis Data were analyzed using repeated-measures ANOVA to evaluate time, group, and interaction effects, with a significance level set at p \< 0.05.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: